Brain inflammation and oxidative stress in a transgenic mouse model of Alzheimer-like brain amyloidosis - PubMed (original) (raw)
Brain inflammation and oxidative stress in a transgenic mouse model of Alzheimer-like brain amyloidosis
Yuemang Yao et al. J Neuroinflammation. 2004.
Abstract
BACKGROUND: An increasing body of evidence implicates both brain inflammation and oxidative stress in the pathogenesis of Alzheimer's disease (AD). The relevance of their interaction in vivo, however, is unknown. Previously, we have shown that separate pharmacological targeting of these two components results in amelioration of the amyloidogenic phenotype of a transgenic mouse model of AD-like brain amyloidosis (Tg2576). METHODS: In the present study, we investigated the therapeutic effects of a combination of an anti-inflammatory agent, indomethacin, and a natural anti-oxidant, vitamin E, in the Tg2576 mice. For this reason, animals were treated continuously from 8 (prior to Abeta deposition) through 15 (when Abeta deposits are abundant) months of age. RESULTS: At the end of the study, these therapeutic interventions suppressed brain inflammatory and oxidative stress responses in the mice. This effect was accompanied by significant reductions of soluble and insoluble Abeta1-40 and Abeta1-42 in neocortex and hippocampus, wherein the burden of Abeta deposits also was significantly decreased. CONCLUSIONS: The results of the present study support the concept that brain oxidative stress and inflammation coexist in this animal model of AD-like brain amyloidosis, but they represent two distinct therapeutic targets in the disease pathogenesis. We propose that a combination of anti-inflammatory and anti-oxidant drugs may be a useful strategy for treating AD.
Figures
Figure 1
Effect of indomethacin plus vitamin E supplementation on markers of brain oxidative stress. Total cerebral cortex homogenates from Tg2576 receiving placebo (open bars) or the combination therapy (closed bars) were assayed for levels of iPF2α-VI (upper panel) and protein carbonyls (lower panel) (*p < 0.01, n = 10 per group).
Figure 2
Effect of indomethacin plus vitamin E supplementation on GFAP levels. GFAP and actin levels were detected by immunoblots in homogenates from total cortex of Tg2576 administered with placebo (open bars) or indomethacin plus vitamin E (closed bars) (*p < 0.02, n = 8 per group).
Figure 3
Effect of indomethacin plus vitamin E supplementation on soluble Aβ levels. Levels of high salt soluble Aβ1-40 and Aβ1-42 in total cortex and hippocampus of Tg2576 on placebo (open bars), or indomethacin plus vitamin E (closed bars) (*p < 0.01, n = 8 per group).
Figure 4
Effect of indomethacin plus vitamin E supplementation on insoluble Aβ levels. Levels of formic acid soluble Aβ1-40 and Aβ1-42 in total cortex and hippocampus homogenates from Tg2576 receiving placebo (open bars) or indomethacin plus vitamin E (closed bars) (*p < 0.001, n = 8 per group).
Figure 5
Effect of indomethacin plus vitamin E supplementation on amyloid deposition. Percentage area of somatosensory cortex (SSC), hippocampus (HIP) and parahippocampal cortex (PHC) occupied by Aβ immunoreactive deposits in Tg2576 receiving placebo (open bars), or indomethacin plus vitamin E (closed bars) for seven months (*p < 0.001; n = 8 per group).
Figure 6
Representative pictures of brain sections from mice on placebo or receiving indomethacin plus vitamin E.
Similar articles
- Reduced effectiveness of Abeta1-42 immunization in APP transgenic mice with significant amyloid deposition.
Das P, Murphy MP, Younkin LH, Younkin SG, Golde TE. Das P, et al. Neurobiol Aging. 2001 Sep-Oct;22(5):721-7. doi: 10.1016/s0197-4580(01)00245-7. Neurobiol Aging. 2001. PMID: 11705631 - TLR4 mutation reduces microglial activation, increases Aβ deposits and exacerbates cognitive deficits in a mouse model of Alzheimer's disease.
Song M, Jin J, Lim JE, Kou J, Pattanayak A, Rehman JA, Kim HD, Tahara K, Lalonde R, Fukuchi K. Song M, et al. J Neuroinflammation. 2011 Aug 9;8:92. doi: 10.1186/1742-2094-8-92. J Neuroinflammation. 2011. PMID: 21827663 Free PMC article. - Age-dependent neuroplasticity mechanisms in Alzheimer Tg2576 mice following modulation of brain amyloid-β levels.
Lilja AM, Röjdner J, Mustafiz T, Thomé CM, Storelli E, Gonzalez D, Unger-Lithner C, Greig NH, Nordberg A, Marutle A. Lilja AM, et al. PLoS One. 2013;8(3):e58752. doi: 10.1371/journal.pone.0058752. Epub 2013 Mar 15. PLoS One. 2013. PMID: 23554921 Free PMC article. - Beneficial Effects of Walnuts on Cognition and Brain Health.
Chauhan A, Chauhan V. Chauhan A, et al. Nutrients. 2020 Feb 20;12(2):550. doi: 10.3390/nu12020550. Nutrients. 2020. PMID: 32093220 Free PMC article. Review. - Alzheimer's disease.
De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV. De-Paula VJ, et al. Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Subcell Biochem. 2012. PMID: 23225010 Review.
Cited by
- In Vitro and In Vivo Insights into a Broccoli Byproduct as a Healthy Ingredient for the Management of Alzheimer's Disease and Aging through Redox Biology.
Navarro-Hortal MD, Romero-Márquez JM, López-Bascón MA, Sánchez-González C, Xiao J, Sumalla-Cano S, Battino M, Forbes-Hernández TY, Quiles JL. Navarro-Hortal MD, et al. J Agric Food Chem. 2024 Mar 13;72(10):5197-5211. doi: 10.1021/acs.jafc.3c05609. Epub 2024 Mar 5. J Agric Food Chem. 2024. PMID: 38477041 Free PMC article. - Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease.
Perluigi M, Di Domenico F, Butterfield DA. Perluigi M, et al. Physiol Rev. 2024 Jan 1;104(1):103-197. doi: 10.1152/physrev.00030.2022. Physiol Rev. 2024. PMID: 37843394 Review. - Recent Development in the Understanding of Molecular and Cellular Mechanisms Underlying the Etiopathogenesis of Alzheimer's Disease.
Afsar A, Chacon Castro MDC, Soladogun AS, Zhang L. Afsar A, et al. Int J Mol Sci. 2023 Apr 14;24(8):7258. doi: 10.3390/ijms24087258. Int J Mol Sci. 2023. PMID: 37108421 Free PMC article. Review. - Alzheimer's Disease and Impaired Bone Microarchitecture, Regeneration and Potential Genetic Links.
Zhang M, Hu S, Sun X. Zhang M, et al. Life (Basel). 2023 Jan 29;13(2):373. doi: 10.3390/life13020373. Life (Basel). 2023. PMID: 36836731 Free PMC article. Review. - A quantitative meta-analysis of vitamin C in the pathophysiology of Alzheimer's disease.
Hamid M, Mansoor S, Amber S, Zahid S. Hamid M, et al. Front Aging Neurosci. 2022 Sep 7;14:970263. doi: 10.3389/fnagi.2022.970263. eCollection 2022. Front Aging Neurosci. 2022. PMID: 36158537 Free PMC article.
References
- Clark CM. Clinical manifestations and diagnostic evaluation of patients with Alzheimer's disease. In: Clark CM, Trojanowski JQ, editor. Neurodegenerative dementias: clinical; features and pathological mechanisms. New York: McGraw-Hill; 2000. pp. 95–114.
- Smith MA, Rottkamp CA, Nunomura A, Raina AK, Perry G. Oxidative stress in Alzheimer's disease. Biochem Biophys Acta. 2000;1502:139–144. - PubMed
LinkOut - more resources
Full Text Sources